HR 9 risk-assessment requirements would add $20 mil. to FDA premarket spending -- CBO.
This article was originally published in The Tan Sheet
Executive Summary
HR 9 RISK ASSESSMENT REQUIREMENTS WOULD ADD $20 MIL. TO FDA SPENDING for premarket regulatory activities each year, the Congressional Budget Office estimates in a report released Feb. 15. The $20 mil. in spending would result from the risk assessment requirement in Title III of the House Commerce Committee's version of the "Job Creation and Wage Enhancement Act" (HR 9).